CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
Details
- Status
- Prescription
- First Approved
- 2018-08-21
- Routes
- INTRAVENOUS
- Dosage Forms
- POWDER
CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER Approval History
What CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER Treats
5 indicationsCEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER is approved for 5 conditions since its original approval in 2018. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Pneumonia
- Febrile Neutropenia
- Urinary Tract Infection
- Skin and Skin Structure Infections
- Intra-Abdominal Infection
Drugs Similar to CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER FDA Label Details
ProIndications & Usage
Cefepime for Injection and Dextrose Injection is a cephalosporin antibacterial indicated in the treatment of the following infections caused by susceptible strains of the designated microorganisms: Pneumonia Empiric therapy for febrile neutropenic patients Uncomplicated and complicated urinary tract infections Uncomplicated skin and skin structure infections Complicated intra-abdominal infections (used in combination with metronidazole) To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefepime for Injection and Dextrose Injection and other antibacterial dr...
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.